Molecular Basis of Pediatric Liver Cancer

Launched by UNIVERSITY OF PITTSBURGH · May 21, 2019

Keywords

ClinConnect Summary

This clinical trial is focused on studying childhood liver cancer to better understand its genetic and molecular characteristics. The goal is to learn how these cancers develop and behave, which can help doctors classify them more accurately and improve treatment options for young patients. This research is important because it may lead to new ways to identify who is more likely to develop liver cancer and how best to treat it.

If your child has received treatment for a liver tumor, either cancerous or non-cancerous, and is under 21 years old, they may be eligible to participate in this study. Families can also take part; biological parents and siblings of the child can join. Participants will be asked to provide information and possibly biological samples, which will help researchers gather important data. The trial is currently recruiting, and it's a chance to contribute to vital research that could improve the future of liver cancer treatment for children.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Prior or current treatment for a childhood liver tumor, malignant or benign, at age \<21 years.
• • Biological parents and siblings of eligible children.
• Exclusion Criteria:
• • No prior or current treatment for a childhood liver tumor.
• • Non-biological parents, legal guardians, or non-biological siblings of eligible children.